1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, November 2016 (p7)

Biological Therapy Analysis & Statistics, November 2016 (p7)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

181-210 of about 1100 reports

Purchase Reports From Reputable Market Research Publishers

BCMA-Targeted Immunotherapeutics in: October 2016 R&D and Business Tracker for Bispecific Antibodies

BCMA-Targeted Immunotherapeutics in: October 2016 R&D and Business Tracker for Bispecific Antibodies

  • $ 220
  • Industry report
  • November 2016
  • by La Merie Publishing

BCMA-Targeted Immunotherapeutics in: October 2016 R&D and Business Tracker for Bispecific Antibodies This pdf report contains information about Bispecific Antibodies released during the month of Octobe ...

  • Industries : Biological Therapy
CD33-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells

CD33-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells

  • $ 220
  • Industry report
  • October 2016
  • by La Merie Publishing

CD33-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells This pdf report contains information about TCR & CAR engineered T-cells and NK cells ...

  • Industries : Biological Therapy
Antisense Therapeutics Limited (ANP) - Financial and Strategic SWOT Analysis Review

Antisense Therapeutics Limited (ANP) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • September 2016
  • by Global Data

Antisense Therapeutics Limited (ANP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

  • Industries : Therapy, Biological Therapy
Japan Tissue Engineering Company Limited

Japan Tissue Engineering Company Limited

  • $ 99
  • Company report
  • November 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Japan Tissue Engineering Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

  • Industries : Biological Therapy
  • Countries : Japan
US Stem Cell Inc

US Stem Cell Inc

  • $ 99
  • Company report
  • November 2016
  • by Wright Investors' Service

A textual analysis of the financial results for US Stem Cell Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Biological Therapy
  • Countries : United States
Antisense Therapeutics Limited

Antisense Therapeutics Limited

  • $ 99
  • Company report
  • October 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Antisense Therapeutics Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biological Therapy
  • Countries : United States, World
Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc.

  • $ 87
  • Company report
  • November 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Northwest Biotherapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : United States
Eleven Biotherapeutics Inc

Eleven Biotherapeutics Inc

  • $ 87
  • Company report
  • November 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Eleven Biotherapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Biological Therapy
  • Countries : United States
Asterias Biotherapeutics Inc

Asterias Biotherapeutics Inc

  • $ 87
  • Company report
  • November 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Asterias Biotherapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : United States
Global Mesenchymal Stem Cells Industry

Global Mesenchymal Stem Cells Industry

  • $ 4950
  • Industry report
  • September 2016
  • by Global Industry Analysts

This report analyzes the worldwide markets for Mesenchymal Stem Cells in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. ...

  • Industries : Biological Therapy
  • Countries : United States, World, Europe, Japan
Immunotherapy Drugs - Global Market Outlook (2016-2022)

Immunotherapy Drugs - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • September 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Immunotherapy Drugs market is accounted for $38.26 billion in 2015 and is expected to reach $97.47 billion by 2022 growing at a CAGR of 14.3%. In present scenario ...

  • Industries : Biological Therapy
  • Countries : World, Europe, North America, Asia
3D Cell Culture Technologies Patent Landscape

3D Cell Culture Technologies Patent Landscape

  • $ 5489
  • Company report
  • September 2016
  • by KnowMade

IP landscape for 3D cell culture technologies offers an important space to big entities as well as for small companies 3D CELL CULTURE : REPRODUCING AN IN VIVO-LIKE ENVIRONMENT IN VITRO The patent landscape ...

  • Industries : Biological Therapy, In Vitro Diagnostics
  • Countries : United States
Global RNAi Technologies Market Analysis & Trends - Industry Forecast to 2025

Global RNAi Technologies Market Analysis & Trends - Industry Forecast to 2025

  • $ 4200
  • Industry report
  • September 2016
  • by Accuray Research LLP

Global RNAi Technologies Market Analysis & Trends - Industry Forecast to 2025 The Global RNAi Technologies Market is poised to grow at a CAGR of around 20.4% over the next decade to reach approximately ...

  • Industries : Biological Therapy
  • Countries : World, Europe, Asia, North America
Global Regenerative Medicine Partnering 2010-2016: Deal trends, players, financials and forecasts

Global Regenerative Medicine Partnering 2010-2016: Deal trends, players, financials and forecasts

  • $ 2995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Regenerative Medicine Partnering 2010-2016: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the regenerative medicine including ...

  • Industries : Biological Therapy, Biotechnology, Pathology, Healthcare, Therapy, Pharmaceutical
  • Countries : United States, North America
R&D and Business Tracker for TCR & CAR T-Cells and NK Cells

R&D and Business Tracker for TCR & CAR T-Cells and NK Cells

  • $ 1320
  • Industry report
  • September 2016
  • by La Merie Publishing

R&D and Business Tracker for TCR & CAR T-Cell and NK Cells - a monthly update service This information service about TCR & CAR engineered T-cells and NK cells delivers 12 monthly update reports in ...

  • Industries : Biological Therapy
R&D and Business Tracker for Bispecific Antibodies

R&D and Business Tracker for Bispecific Antibodies

  • $ 1320
  • Industry report
  • September 2016
  • by La Merie Publishing

R&D and Business Tracker for Bispecific Antibodies- a monthly update service This information service about Bispecific Antibodies delivers 12 monthly update reports in pdf format by e-mail straight ...

  • Industries : Biological Therapy
Allergic Asthma Global Clinical Trials Review, H2, 2016

Allergic Asthma Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Allergic Asthma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Allergic Asthma Global Clinical Trials Review, H2, 2016" provides an overview of Allergic Asthma clinical ...

  • Industries : Drug Discovery and Development, Chronic Disease, Pharmaceutical, Pathology, Therapy
  • Countries : World
Bronchiolitis Obliterans Global Clinical Trials Review, H2, 2016

Bronchiolitis Obliterans Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Bronchiolitis Obliterans Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Bronchiolitis Obliterans Global Clinical Trials Review, H2, 2016" provides an overview of ...

  • Industries : Therapy, Pharmaceutical, Biological Therapy, Biotechnology
  • Countries : World
Aplastic Anemia Global Clinical Trials Review, H2, 2016

Aplastic Anemia Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Aplastic Anemia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Aplastic Anemia Global Clinical Trials Review, H2, 2016" provides an overview of Aplastic Anemia clinical ...

  • Industries : Pathology, Cancer, Drug Discovery and Development, Pharmaceutical, Healthcare
  • Countries : World
Fanconi Anemia Global Clinical Trials Review, H2, 2016

Fanconi Anemia Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Fanconi Anemia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Fanconi Anemia Global Clinical Trials Review, H2, 2016" provides an overview of Fanconi Anemia clinical ...

  • Industries : Pathology, Drug Discovery and Development, Healthcare
  • Countries : World
Cystic Fibrosis Global Clinical Trials Review, H2, 2016

Cystic Fibrosis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Cystic Fibrosis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Cystic Fibrosis Global Clinical Trials Review, H2, 2016" provides an overview of Cystic Fibrosis clinical ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Pathology
  • Countries : World
Sepsis Global Clinical Trials Review, H2, 2016

Sepsis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Sepsis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Sepsis Global Clinical Trials Review, H2, 2016" provides an overview of Sepsis clinical trials scenario. This ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Pathology, Therapy, Healthcare
  • Countries : World
Neutropenia Global Clinical Trials Review, H2, 2016

Neutropenia Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Neutropenia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Neutropenia Global Clinical Trials Review, H2, 2016" provides an overview of Neutropenia clinical trials ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Therapy
  • Countries : World
Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2016

Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of ...

  • Industries : Pathology, Healthcare, Therapy
  • Countries : World
Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2016

Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of ...

  • Industries : Therapy, Pathology, Biopharmaceutical, Pharmaceutical, Cancer, Biotechnology, Biological Therapy
  • Countries : World
Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2016

Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Chronic Disease, Pathology, Therapy
  • Countries : World
Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2016

Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2016" provides ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World
Burns - Pipeline Review, H2 2016

Burns - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Burns - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Burns - Pipeline Review, H2 2016’, provides an overview of the Burns pipeline landscape. The report provides comprehensive information ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States, World, Europe
Myocardial Ischemia - Pipeline Review, H2 2016

Myocardial Ischemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Myocardial Ischemia - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Myocardial Ischemia - Pipeline Review, H2 2016’, provides an overview of the Myocardial Ischemia pipeline landscape. ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, World, Russian Federation
Dystrophin (DMD) - Pipeline Review, H2 2016

Dystrophin (DMD) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Dystrophin (DMD) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Dystrophin (DMD) - Pipeline Review, H2 2016’, provides in depth analysis on Dystrophin (DMD) targeted pipeline therapeutics. ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical
  • Countries : United States, World
About 2800 reports

Download Unlimited Documents from Trusted Public Sources

Medigene AG - Investor Report, December 2016

  • December 2016
    39 pages
  • Immunotherapy  

    Cell Therapy  

  • Germany  

View report >

Filgrastim Industry

December 2016

Microrna Industry

November 2016

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.